Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain | Saint-Louis

Displaying 2 results.

- Journal article
CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial.
Laterre, Pierre-François[UCL] Colin, Gwenhael Dequin, Pierre-François Dugernier, Thierry Boulain, Thierry Azeredo da Silveira, Samareh Lajaunias, Frédéric Perez, Antonio François, Bruno (2019) The Lancet. Infectious diseases — Vol. 19, no.6, p. 620-630 (2019)
- Journal article
Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial.
François, Bruno Jafri, Hasan S Chastre, Jean Sánchez-García, Miguel Eggimann, Philippe Dequin, Pierre-François Huberlant, Vincent Viña Soria, Lucia Boulain, Thierry Bretonnière, Cédric Pugin, Jérôme Trenado, Josep Hernandez Padilla, Ana Catalina Ali, Omar Shoemaker, Kathryn Ren, Pin Coenjaerts, Frank E Ruzin, Alexey Barraud, Olivier Timbermont, Leen Lammens, Christine Pierre, Vadryn Wu, Yuling Vignaud, Julie Colbert, Susan Bellamy, Terramika Esser, Mark T Dubovsky, Filip Bonten, Marc J Goossens, Herman Laterre, Pierre-François[UCL] COMBACTE Consortium and the SAATELLITE Study Group (2021) The Lancet. Infectious diseases — Vol. 21, no.9, p. 1313-1323 (2021)